Jeff Frelick - 08 Jan 2026 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Chief Executive Officer
Signature
/s/ Jeff Frelick
Issuer symbol
BBLG
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 16:37:13 UTC
Previous filing
21 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Frelick Jeff Chief Executive Officer C/O BONE BIOLOGICS CORP,, 2 BURLINGTON WOODS DR.SUITE 100, BURLINGTON, /s/ Jeff Frelick 20 Jan 2026 0001645093

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BBLG Common Stock 360 08 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Employee Stock Option Award $0 +16,668 $0.000000 16,668 08 Jan 2026 Common Stock 16,668 $1.55 Direct F1
holding BBLG Employee Stock Option 9,019 08 Jan 2026 Common Stock 9,019 $5.82 Direct F2
holding BBLG Employee Stock Option 8 08 Jan 2026 Common Stock 8 $73800.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
F2 This option is fully vested as of the date of this report.